Consistent with the national priority of reducing racial disparities in health, many studies have evaluated the negative association of black race and low socioeconomic status (SES) with outcomes across medical conditions and health care settings. 1, 2 However, disentangling these effects has proven to be challenging. Nearly every indicator of SES is highly correlated with race, with US blacks bearing a disproportionate burden of poverty and inequality compared with whites. 3, 4 Although many studies have demonstrated that racial disparities in health outcomes are mediated, at least in part, by socioeconomic factors, few have had large and diverse enough cohorts to separate the inter-related roles of race and SES on outcomes.
Acute myocardial infarction (AMI) is an ideal condition in which to investigate the interplay of these factors because racial and socioeconomic disparities in cardiovascular risk factors, management, and outcomes are well documented. However, few studies in the AMI literature have had sufficient numbers or detailed clinical information to evaluate race and SES together to disentangle their effects, [5] [6] [7] [8] [9] [10] and examine of black-white differences in outcomes across SES levels. 5, 11 In addition, no studies have assessed whether the association of race and SES with outcomes changes with age. Because blacks and those with lower SES have shorter life expectancies, individuals with these characteristics who reach the oldest ages may be healthier and thus racial differences in mortality may diminish as age increases.
Accordingly, the objectives of this study were to evaluate the relationship between race and area-level SES on post-AMI life expectancy and to determine whether area-level SES modifies the effect of race in this relationship. With detailed medical record data, demographic information and 17 years of follow-up for over 140,000 patients with AMI, the Cooperative Cardiovascular Project provides a unique opportunity to investigate this question. Additionally, the use of life expectancy allows us to separate the effects of race and area-level SES by nterplay of these factors because racial and socioeconomic disparities in cardiov vas as ascu cu cula la lar r r ri ri risk sk sk factors, management, and outcomes are well documented. However, few studies in the AMI itera ra atu tu ture re re h h hav av ave ha a
ad d d sufficient numbers or detailed ed d cl cl clinical information t t to o o ev e e aluate race and SES
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Methods

Data Source
Data from the CCP were used for this study. 12, 13 Conducted in the mid-1990's by the Health Care
Financing Administration, the CCP was a prospective cohort study focused on improving the care of patients with AMI in the U.S. The CCP includes fee-for-service Medicare beneficiaries discharged from nongovernmental acute-care hospitals with a principal discharge diagnosis of Financing Administration, the CCP was a prospective cohort study focused on im m mpr pr prov ov ovin in ing g g th th the e e care of patients with AMI in the U.S. The CCP includes fee-for-service Medicare beneficiaries disc cha ha harg rg rged ed ed f f fro ro r m m no no ongovernmental acute-care hos os ospi pi pita t ls with a principal l l di d d scharge diagnosis of
AM AM AMI (Internatio io iona na n l Cl Cl Clas as assi si sifi fi fi ( ca ca cati ti tion on n o o of f f Di D D s seas s ses es s, 9 th h h R R Rev vis is isio io ion, n, n, C C Cli li ini n n ca ca cal l l M M Mod difica ca cati ti tion on n ( ( (IC IC ICD D D-9-9-9-CM CM CM) ) )
co o ode de de 410). I I Ind nd ndiv vid id idual st t tates w w wer er ere sa sa samp mp mple e ed du du dur r ring a rand nd ndom om m 8-m -m mon on onth th h p pe e eriod be be betw t ee e en n n Janu nu uary 19 19 1994 Census (n=5,648) to assess area-level SES were also excluded. Finally, because this study focuses on black-white differences in life expectancy after AMI, we excluded patients who were classified as races other than black and white (n=9,010). Our final sample size included 141,095 patients with AMI. This study was approved by the Yale University institutional review committee.
Variable Definitions
Information on patient-identified race was obtained from the medical record and was categorized as black or white. Cens ns sus us us ( ( (n= n= n=5, 5, 5,648) 8) 8) t t to assess area-level SES were e a a als ls lso o excluded. Finally, y, , b b because this study fo fo focu u uses on bla l ck ck ck-w whi hi hit t te d d dif if iffe fe fere re ren n nce e es i i in n li l l f fe ex x xpe e ectan nc c cy a a aft ft fte er er A A AMI MI MI, , we we we e e ex x xclu ude e ed d d pa pa pati ti tien en ents s s w w who ho ho w w wer er ere cl l la as a si si sified as s s r ra r ce e es othe e er r r than n n b b bla la lack k k a a and Medicare. Time to death was calculated from admission and censored at 17 years.
Statistical Analyses
We compared baseline characteristics of black and white patients overall and across different SES levels using X 2 tests for categorical variables and ANOVA for continuous variables. Age, race, and SES-specific estimates of life expectancy were calculated using Cox proportional hazards models with covariates age, race, area-level SES, and their pairwise interactions (S1 Table) . Sex was also included in the model as a main effect only because interactions between sex with race and SES were not significant. Proportional hazards assumptions were assessed using Schoenfeld residuals, examined graphically, and tested formally; all assumptions were met.
We defined life expectancy as mean survival after AMI, which was calculated by plotting the expected survival curves for each age, race, and SES combination and then extrapolating the curves to age 100 using exponential models. Exponential models were selected because we lacked information on the shape of the survival curves after follow-up and therefore chose the most conservative approach. Similarly, we chose to extrapolate the curves to age 100 because the Centers for Disease Control and Prevention uses age 100 as the upper threshold for life expectancy estimates in the general population. 14 The constant hazard for the exponential model was specified as the average hazard over the last 2 years of follow-up. For example, to calculate life expectancy for 65-year-old white patients with high SES, we plotted the survival curve for these specific covariate values over 17 years of follow-up and then extrapolated the survival curve using an exponential model over an additional 18 years. Mean survival estimates were calculated by summing the area under the individual survival functions. Ninety-five percent ex with race and SES were not significant. Proportional hazards assumptions wer er ere e e as as asse se sess ss ssed ed ed using Schoenfeld residuals, examined graphically, and tested formally; all assumptions were met
We d d def ef efin in ined ed ed l l lif i i e ex ex expe p ctancy as mean survival afte te ter r r AM A A I, which was cal l lcu cu culated by plotting the ex ex exp pe p cted surviva va val cu cu urv rv rves es es f f for or or e e eac ac ach h h ag ag ge, ra ace, an n nd SE SE ES co co comb mb mbin in inat a a io io ion an an and d d t t the en e e ext xt xtra ra rapo po pola la lati i in n ng t t the he he cu u urv rv rves e e to ag g ge e e 100 0 0 u us u in n ng expo o one e ent n ia a al l l m m mod de d ls s s. . E E Expon on nent t tia a al m m mod d del e e s s s we we were r r se elec c cte te ted d d beca ca cau u use e w w we a a ack ck cked ed ed i i inf nf nfor or orma ma mati ti tion on on o o on n n th th the e e sh sh shap ap ape e e of of of t t the he he s s sur r urvi i viva a val l l c c cur r urve e ves s s af af afte te ter r r fo fo foll ll llow o ow-up p p an an and d d th th ther er eref ef efor or ore e e ch ch chos os ose e e th th the e e confidence intervals for mean survival were calculated using the upper and lower confidence limits of the expected survival curves.
To determine whether differences in patient characteristics explained the observed differences in life expectancy by race, we repeated calculations of life expectancy adjusting for cardiovascular risk factors, clinical presentation, and therapies received (S2 Table) . Age-specific covariate frequencies in the overall sample were used to generate the expected survival curves, and these curves were again extrapolated to age 100 using exponential models. By fixing covariates at the same value for black and white patients and patients residing in low and high SES areas, we could estimate the net differences in life expectancy attributable to race and SES alone. Covariates were selected using prior literature and clinical judgment and included preexisting cardiovascular risk factors (history of diabetes mellitus, hypertension, congestive heart failure, coronary artery disease, smoking, and renal insufficiency), clinical presentation (STelevation AMI, cardiac arrest, and Killip class >2), and treatment (revascularization procedure within 30 days and fibrinolytic therapy). Patients with missing data on percutaneous coronary intervention and coronary artery bypass grafting procedures were included in the model using a dummy variable for missing data. All other variable information was complete. P-values <0.05
were considered statistical significant for model interactions. All variable definitions and statistical analyses were determined a priori and were performed using SAS 9.2 (SAS Institute, Cary, NC).
Results
Of the 141,095 patients with AMI in our cohort, 6.3% were black and 6.8% were classified as residing in low SES areas using ZIP code-level median household income. The mean age of the alone. Covariates were selected using prior literature and clinical judgment and inc nc nclu lu lude de ded d d pr pr pre-e-eexisting cardiovascular risk factors (history of diabetes mellitus, hypertension, congestive heart failur ur ure, e, e, c c cor or oron on onary y y ar ar artery disease, smoking, and re e ena na nal l l insufficiency), clin nic ic ical a a presentation (STel el elev v vation AMI, c c car rdi di ia a ac a a arr rr rre es e t, t, t, a a and nd nd K K Kil il illi l l p p cl l la a ass s s >2) ), and d d t t tr r reat a a me me ment n nt ( ( (re re reva va vasc sc s ular r riz iz iz t at atio io ion n n pr pr pro oc o ed ed edur ur ure wi wi with th thin in i 30 da a ays y y a and nd nd fib b bri i inoly y yti t t c c c th t er er ra a apy y y). . . Pa at t tie e ents w with h m m miss s sin in ing g g da da ata a a o o on pe pe percu u utan an aneous us us cor ron n nary y y n n nte te terv r rven en enti ti tion on on a a and nd nd c c cor or oron on onar ar ary ar ar arte te tery r ry by b bypa pa pass ss ss g g gra ra raft ft ftin in ing g g pr pr proc oc oced ed edur r ures es es wer er ere e e in in incl cl clud d uded ed ed i i in n n th th the e e mo mo mode de del l l us s usin in ing g g a a a sample was 75.9 (standard deviation 6.7) years. The distribution of area-level SES differed by race with significantly more black patients characterized as residing in low SES areas compared with white patients (26.0% vs. 5.7%, p<0.001) ( Table 1) . Black patients had a higher prevalence of most cardiovascular risk factors, including diabetes, hypertension, congestive heart failure, and smoking, and were more likely to be classified as Killip class III or IV at the time of presentation. In addition, they were significantly less likely to undergo acute revascularization procedures and to receive fibrinolytic therapy. These differences between black and white patients persisted across all levels of SES, even though overall rates of comorbidities, clinical variables, and treatment differed by area-level SES ( Table 2) .
After 17 years of follow-up, the survival rate was 7.4% for white patients and 5.7% for black patients; however these rates also differed by area-level SES. Among white patients, survival rates were 9.1% for patients residing in high SES area, 7.0% for patients in medium SES areas, and 5.4% for patients in low SES areas. The corresponding rates in black patients were 7.1%, 5.7%, and 5.2%, respectively (S3 Table) .
Life expectancy estimates after AMI are shown in Figures 1 and 2 stratified by age, race, and SES. For white patients aged <80 years, patients living in high SES areas had the longest life expectancy after AMI, followed by patients in medium SES areas, and then patients in low SES areas (S4 Table) . In contrast, post-AMI life expectancy was similar for black patients residing in medium and low SES areas across all ages. Only black patients living in high SES areas aged <75 years had a survival advantage compared with low and medium SES blacks; black patients aged >75 years had similar post-AMI life expectancies across all levels of SES.
To evaluate the effect of area-level SES on racial disparities in life expectancy after AMI, we plotted the absolute difference between white and black life expectancies for each level of After 17 years of follow-up, the survival rate was 7.4% for white patients a a and nd nd 5 5 5.7 .7 .7% % % fo fo for r r black patients; however these rates also differed by area-level SES. Among white patients, urv viv iv ival al al r r rat at ates es es we e ere e e 9.1% for patients residing in n h h hig ig igh SES area, 7.0% f f for or or patients in medium SES ar ar area a as, and 5.4% % % fo f for pa pa pa i ti ien en ents ts ts i i in n n l lo low w w SE SE SES area a as. . . The e c c corr rr res es espo po on n ndin in i g g g ra ra rate te tes s s in n bla a ack ck ck p p pat at atie ie ient nt nts s s we we were re re n 7.1% 1% 1%, , , 5.7% %, , , a a and d 5.2% % %, r re r spe e ecti ti tive v ly ly ly (S S S3 T Tab b ble e e). )
Li Li Life fe fe e e exp p xpec ec ecta ta tanc nc ncy es es esti ti tima ma mate te tes s s af af afte te ter r r AM AM AMI I I ar ar are e e sh sh show o own n n in in in Fi Fi Figu g gure re res s s 1 1 1 an an and d d 2 2 2 s s str tr trat at atif if ifie ie ied d d by b by a a age ge ge, ra ra race ce ce e SES (Figure 3) . Differences in white-black life expectancy were largest among patients living in high and medium SES areas and smallest among patients in low SES areas (S5 Table) . Among patients aged 65 years at the time of AMI, white patients outlived black patients in high SES areas by 3.25 (standard error (SE), 0.39) years on average, whereas white patients in low SES areas lived 2.15 (SE 0.59) more years than black patients in low SES areas. As age at AMI increased, the difference in white-black life expectancy narrowed across all levels of SES. In fact, the life expectancy of black patients exceeded that of white patients for patients >81 years of age in low SES areas and patients >86 years of age in medium SES areas (p<0.05).
After adjustment for patient and treatment characteristics, differences in post-AMI life expectancy by race persisted; however, the absolute differences in white-black life expectancy decreased. Figure 4 shows the adjusted differences in white-black life expectancy by area-level SES. Again, the smallest white-black gap in life expectancy was observed in patients residing in low SES areas (p=0.02 for low SES*race interaction); however, for older patients, black race was now associated with longer life expectancies than white patients across all levels of SES.
Life expectancy in black patients exceeded that in white patients of the same age for patients >71 years of age in low SES areas, >74 years of age in medium SES areas, and >83 years of age in high SES areas (p<0.05). In fact, after adjustment, black race predicted shorter life expectancies only for patients <68 years of age residing in high and medium SES areas (p<0.05), but the magnitude of these differences was attenuated compared with unadjusted analyses. Among 65-year-old patients, white life expectancy exceeded black life expectancy by 0.93 (SE 0.34) years in high SES areas and by 0.59 (SE 0.17) years in medium SES areas (S6 Table) . In contrast, among 90-year-old patients, black life expectancy exceeded white life expectancy by 0.49 (SE expectancy by race persisted; however, the absolute differences in white-black life fe fe e e exp xp xpec ec ecta ta tanc nc ncy y y decreased. Figure 4 shows the adjusted differences in white-black life expectancy by area-level
SES. S. . A A Aga ga gain in in, , , th t t e sm sm mallest white-black gap in life e ex ex exp p pectancy was observ ve ved d d in patients residing in
o o ow w w SES areas (p (p (p= =0.0 0 02 2 2 fo fo for r r lo lo low w w SE SE SES* S* S*ra ra ace i i int nt nter r racti ion n n); ho ho howe we wev v ver, r for or or o old ld lder r pat at tie ie ient nt nts, s, s, b b bla lack ck ck r r rac ac ace e e wa wa as no n n w asso so socia at a e ed e w w with h h long ng nger er er lif f fe e e ex x xpe e pecta an anc c cies th h han n n w w whit t te e e pa pa pati i ien n nt f f f f f f s s s ac c cro oss a all ll ll lev vel el els s s of f S S SES. . .
Li Li Life fe fe e e exp p xpec ec ecta ta tanc nc ncy in in in b b bla la lack ck ck p p pat at atie ie ient nt nts s s ex e exce ce ceed ed eded ed ed t t tha ha hat t t in in in whi hi hite te te p p pat at atie ie ient nt nts s s of of of t t the he he s s sam am ame e e ag ag age e e fo fo for r r pa pa pati ti tien en ents ts ts > > >71 71 71 1 0.16) years in high SES areas, by 0.60 (SE 0.10) years in medium SES areas, and by 0.81 (SE 0.14) years in low SES areas.
Discussion
In this large, nationally representative cohort of elderly patients with AMI, we found that black patients and patients residing in low SES areas were disadvantaged with regards to life expectancy. In addition, we found that area-level SES modified the effect of black race on life expectancy after AMI. Black and white patients living in low SES areas had similar unadjusted and adjusted life expectancy whereas among patients living in higher SES areas, black patients had shorter life expectancies than white patients. The associations also varied by age with the disparities being most prominent among the younger patients.
These findings further indicate that black patients have a survival disadvantage after AMI for three reasons. First, there was a significantly higher percentage of black patients living in low SES areas, which is an independent predictor of poor survival after AMI. Second, the greatest gaps in white-black life expectancy occur in patients with the most area-level resources, so even black patients who live in high SES areas are significantly disadvantaged compared with white patients. And finally, black patients tend to have higher rates of cardiovascular risk factors and comorbidities and are significantly less likely to receive reperfusion therapies than white patients. Adjustment for these differences in presentation and treatment attenuated much of the white-black disparity in life expectancy and actually reversed the association between race and life expectancy in older patients.
Our finding that association of race with AMI outcomes across SES levels has not been previously reported. Prior studies have only treated SES as a confounder in the relationship had shorter life expectancies than white patients. The associations also varied by a a age ge ge w w wit it ith h h th th the e e disparities being most prominent among the younger patients.
Th Th Thes es ese e e find nd ndin i i gs further indicate that black k k p p pat a a ients have a surviva va val l l disadvantage after AMI fo fo for t three reason n ns s. s F Fir r rst st st, th th ther er ere e wa wa w s s a si si sig g gni ifica a ant tl t y h hig g gher er r p p per r rce ce cent nt tag ag age e e of of of b b bl la lack p p pat at ati ie ient nt nts s s li ivi vi ving ng g i i in n n lo lo low SE E ES S S ar a a eas, w w whi h h ch h h i i is an n n i i indep p pen n nde d d nt nt nt p pre re ed di d cto o or o of p p poo o or su su surv r iv v va a al a a aft ft fter r r A A AM M M f I. . Se ec eco o ond, t t the he he gr rea atest t t ga ga gaps ps ps i i in n n wh h whit it ite e e-bl bl blac ac ack k k li li life fe fe e e exp p xpec ec ecta ta tanc nc ncy o o occ cc ccur r ur i i in n n pa pa pati ti tien en ents ts ts wit it ith h h th th the e e mo mo most st st a a are re rea a a-le le leve e vel l l re re reso so sour r urce ce ces s s, s s so o o ev e even en en t t t between race and mortality and have generally reported little or no change in the effect of race after controlling for SES. To our knowledge, only two studies have evaluated interactions between race and SES, and both have reported null results. 5, 11 Spertus et al. measured individual SES using self-reported household income at the time of hospitalization and found a nonsignificant race-by-income interaction on 2-year mortality. 5 Likewise, Ng et al. assessed
interactions between insurance status and race and found that the effect of race was not modified by insurance status when other confounders were taken into account. 11 Several reasons may explain why the results of these studies differ from ours. First, both were relatively small, with fewer than 5000 patients, and may have been underpowered. Second, these studies used patientlevel variables to evaluate SES, whereas we used zip-code level income and thus measured arealevel SES. Although there is much debate on the benefits of using patient versus area-level SES, prior studies have shown that area-level SES is strongly associated with mortality after AMI, [15] [16] [17] [18] and may reflect health-related behaviors and quality of care more accurately than individuallevel SES.
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Our data are consistent with the diminishing returns hypothesis. This theory, first proposed by Farmer and Ferraro, posits that blacks do not receive the same improvements in health as whites with increasing SES, and thus racial differences in health are largest among patients with the most resources. 20 Accordingly, we noted that racial differences in post-AMI life expectancy were greatest in patients residing in high SES areas and smallest in patients living in low SES areas. Several theories have been proposed to explain the diminishing returns hypothesis. Studies examining neighborhood influences on health have described an "ethnic density" effect, whereby minorities living in areas with few of their own racial/ethnic group tend to have poorer health than those living in areas with more of their own. 21, 22 Because wealthy evel variables to evaluate SES, whereas we used zip-code level income and thus me me meas as asur ur ured ed ed a a are re read evel SES. Although there is much debate on the benefits of using patient versus area-level SES, prio or r r st st stud ud udie ie ies s s ha h h v ve ve s shown that area-level SES is s s str tr tron ongly associated with h h m m mortality after AMI, [15] [16] [17] [18] an an and d d may reflect t t he h heal lth th th-r r rel el elat at ated ed d b b beh eh ehav av avio io iors s and nd nduali ity y y of f f ca ca care re e m m mor ore e e ac ac accu cu cura r r t tely y y t t tha ha han n n in in indi d d vi vi vidu du dual al al---e ev ve vel l l SES.
O O Our r ur d d dat at ata a a ar ar are e e co co cons ns nsis is iste te tent nt nt wit it ith h h th th the e e di di dimi i mini i nish h shin i ing retu t turns hy h hypoth th thesis i is.
Th Th This is is t t the he heor or ory, f f fir ir irst st st neighborhoods tend to have a greater concentration of white households, blacks living in these areas may experience less social cohesion and receive less support from peers than those living in low-income areas. 23 This support may be particularly important in the setting of AMI when learning how to manage their condition or requiring assistance with activities of daily living. In addition, blacks living in high-income white neighborhoods may experience greater discrimination than those living in black neighborhoods, 23, 24 which can, in turn, adversely affect physical and mental health. 25, 26 Racial discrimination, whether perceived or actual, has been shown to increase cardiovascular disease risk and negatively impact health outcomes.
In this study, we also observed the phenomenon of racial crossover, whereby blacks have lower life expectancies than whites until age 80-85 and then start to outlive their white peers. 27 This phenomenon has been reported in numerous studies and has been attributed to higher mortality among sicker black patients who never reach the oldest ages. [28] [29] [30] It is hypothesized that the early hardships and chronic stress faced by U.S. blacks accumulate over the life course, leading to earlier onset of chronic diseases and increased mortality beginning in midlife. 27, 31 Thus, blacks who reach older ages represent a healthier cohort than whites of similar ages because they have outlived their average life expectancy in the general population.
Our findings have important implications for national efforts to understand and eliminate racial disparities and for future research on health disparities. First, area-level SES did not explain the observed racial disparities in post-AMI life expectancy in our study. Instead, blackwhite differences in life expectancy were reduced after adjustment for racial differences in comorbidites and treatment suggesting that these factors are primarily responsible for the racial disparity. Second, the widest gap in white-black life expectancy was observed in patients living in the highest SES areas suggesting that racial disparities may be amplified in patients with the ower life expectancies than whites until age 80-85 and then start to outlive their w w whi hi hite te te p p pee ee eers rs rs. 27 27 27 This phenomenon has been reported in numerous studies and has been attributed to higher mort rt tal al alit it ity y y am am amon o o g g g si si sicker black patients who neve er r r r re rea ach the oldest ages. 28-28 28 30 It is hypothesized tha Th Th Thus s us, bl bl blac ac acks ks ks who ho ho r r rea ea each ch ch o o old ld lder er er a a age ge ges s s re re repr pr pres es esen en ent t t a a a he he heal al alth th thie ie ier r r co co coho ho hort rt rt t t tha ha han n n wh h whit it ites es es o o of f f si si simi mi mila la lar r r ag ag ages es es most area-level resources. Taken together, these findings suggest that improving area-level SES may improve outcomes for black and white patients globally but is unlikely to eliminate racial disparities in health. Instead efforts aimed at reducing health disparities should focus on reducing the cardiovascular risk factor burden in black patients and ensuring equitable delivery of guideline-based therapies. Clinically, these findings imply that interventions should target primary prevention and management of comorbid conditions in black patients and that public policies should address fair and equitable delivery of in-hospital treatments for AMI. Additional research is needed to understand why patients living in the highest SES areas have the greatest racial gap in post-AMI life expectancy and whether this phenomenon extends to other cardiovascular and non-cardiovascular diseases. Additionally, a better understanding of the factors that contribute to the variation in white-black life expectancy across SES levels is needed in order to better address racial disparities in outcomes.
This study has some limitations. First, the percentage of black patients and patients living in low SES areas was relatively small in CCP (6.3% and 6.8%, relatively). This resulted in small sample sizes in some of the older age, race, and SES-specific strata, which may have limited the predictive power of our models. To minimize this limitation, we modeled the entire cohort as a whole using semiparametric techniques to avoid stratum-specific estimation. Second, we used ZCTA ZIP-code level median household income rather than data from smaller geographic areas to measure area-level SES. Smaller regions such as Census tracts and blocks may more closely approximate neighborhood SES because they reflect more homogeneous groupings of individuals; however, we lacked data at this level to classify patients accordingly. As a result, we may have misclassified some patients into higher or lower SES levels, but the misclassification should have occurred in both directions and thus would likely bias our results to the null. cardiovascular and non-cardiovascular diseases. Additionally, a better understandi di ding ng ng o o of f f th th the e e factors that contribute to the variation in white-black life expectancy across SES levels is needed n ord rd rder er er t t to o o be be better r r a a add d ress racial disparities in outc tc tcom om omes.
This stu u ud dy dy has as as som om ome e e li li limi mi mita ta tati ti tion on ons. s s Fir ir i st s s , the pe e ercen en enta ta tage ge ge of f f bl b b ac ac ack k k p pa p t tien nts ts ts a a and nd nd p p pat atie ie ient nt ts s s li li livi vi vin ng n n n n l l low ow ow SES a a ar r reas s s w w was re el e ativ v vel el ely y y sm m mal a a l in in in CC C CP ( (6.3% 3% 3% a and nd nd 6.8 .8 8%, %, %, r rel el elat ativ iv i ely y) y . Th Th This i i res s sul ul ulted d i in sma m mall a a amp mp mple le le s s siz i izes es es i i in n n so so some me me o o of f f th th the e e ol ol olde de der r r ag ag age e e, r r rac ac ace e e, a a and nd nd S S SES ES ES s s -spe pe peci ci cifi fi fic c c st st stra ra rata ta ta, wh h whic ic ich h h ma ma may ha ha have e ve l l lim im imit it ited ed ed t t the he he Additionally, because the ZCTA ZIP codes are derived from Census blocks, they may not reflect patient address ZIP codes. Thus, some patients may be placed into ZCTA ZIP codes not reflected by their address. Third, approximately 7% of patients in CCP were still alive after 17 years of follow-up, which required extrapolation of the survival curves in order to calculate life expectancy. We chose to use an exponential model with constant hazard to extrapolate the curve;
however, it is possible that this approach may have over or under-estimated survival. Fourth, we were unable to standardize our estimates against the general population in order to assess how the burden of AMI differs by SES and race. Thus, it is unclear whether the socioeconomic and racial differences in life expectancy we observed are disease-specific or also found in the general population. Finally, there have been several national efforts to understand and reduce racial and socioeconomic disparities in health since the mid-1990's when CCP was conducted.
Additionally, practice patterns and the quality of AMI care has greatly improved. Nevertheless, data from nationally representative cohorts suggest that although racial differences in mortality after AMI have declined over time, there remains a persistent disparity. 32 Thus, although the magnitude of black-white differences in post-AMI life expectancy today may differ from that in the mid-1990's, we expect that the relationship between race, socioeconomic status, and life expectancy is similar, making our findings highly relevant for researchers and policy-makers today.
Although this study has its limitations, it also has several strengths which make these analyses possible. First, life expectancy calculations require complete follow-up over many years which most datasets lack. Second, evaluating the interplay between race and SES necessitates an immense dataset with sufficient numbers of black and white patients at all SES levels to examine interactions. Given the high collinearity between SES and race, most datasets do not have population. Finally, there have been several national efforts to understand and red d duc uc uce e e ra ra raci ci cial al al a a and n n ocioeconomic disparities in health since the mid-1990's when CCP was conducted.
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In conclusion, we found racial differences in post-AMI life expectancy varied significantly by area-level SES with the largest differences observed in patients living in high SES areas and younger age. Thus, SES did not explain racial differences, but these differences were reduced by adjustment for comorbidities and treatment. These findings illustrate the complex interaction between race and SES in post-AMI prognosis and highlight the need for additional research investigating racial and socioeconomic differences in post-AMI care and practice patterns. T T The he he a a ass ssoc oc ociati ti ion on on bet e etwe we een s s soc oc ocio io ioecon on nom omic ic ic po po posi si siti ti tion on on, us s use e e of of of r r rev e evas as ascu c cula la lari ri riza a zati ti tion on on pr pr proc oc oced ed edur r ures es es, an an and d d fi fi five e ve-yea ea ear r r su s surv r rviv i ival al al a a aft ft fter er er r r rec ec ecov o over er ery fr fr from om om a a acu c cute te te 
